-
1.
公开(公告)号:US20240127956A1
公开(公告)日:2024-04-18
申请号:US18488373
申请日:2023-10-17
申请人: Osaka University , National Institutes of Biomedical Innovation, Health and Nutrition , Kagami Inc.
发明人: Yoshitaka ISAKA , Tomonori KIMURA , Shihoko KIMURA , Masashi MITA
CPC分类号: G16H50/20 , G01N33/6893 , G16H20/10 , G01N2800/52
摘要: Provided herein is a method for providing information about virus infection and/or virus infection disease in a subject, comprising: making a determination on the detection and/or stage classification of virus infection and/or virus infection disease in the subject using an indicator associated with a D-amino acid in the subject; and providing information about virus infection and/or virus infection disease in the subject based on the results of the determination.
-
公开(公告)号:US20230063703A1
公开(公告)日:2023-03-02
申请号:US17800306
申请日:2021-02-18
申请人: Keio University , Kagami Inc.
IPC分类号: A61K31/197 , A23L33/175 , A61P29/00 , A61P1/04 , A61P1/16 , A61P31/14
摘要: The present invention provides a drug for treating and/or preventing enteritis and/or hepatitis, said drug containing D-amino acid as an active ingredient. In addition, the present invention provides a food composition for suppressing enteritis and/or hepatitis, said composition containing D-amino acid as an active ingredient. In addition, the present invention provides a method for assisting diagnosis of enteritis and/or hepatitis in a subject, said method using the amount of D-amino acid in the intestinal tract as an indicator.
-
公开(公告)号:US20230037869A1
公开(公告)日:2023-02-09
申请号:US17789402
申请日:2020-12-25
发明人: Masashi MITA , Tatsuhiko IKEDA , Tomonori KIMURA
摘要: The present invention provides a method comprising a step of estimating the kidney function of an arbitrary subject by a regression analysis which employs the amount of a D, L-amino acid in a biological sample from the arbitrary subject as an explanatory variable and employs the amount of filtrated glomeruli in the arbitrary subject as an object variable, by employing a previously determined formula (I): Y=a1·X1+a2·X2+ . . . +an·Xn+b (I) [wherein a1 to an independently represent a constant obtained by the regression analysis; X1 to Xn independently represent a variable of the amount of the D,L-amino acid which is selected by the regression analysis; and b represents a constant obtained by the regression analysis] on the basis of the Y value calculated from the amount of the D, L-amino acid in the biological sample from the object to be evaluated. Also provided is a system for carrying out the method.
-
公开(公告)号:US20220252610A1
公开(公告)日:2022-08-11
申请号:US17441638
申请日:2020-03-23
发明人: Masashi MITA , Tatsuhiko IKEDA , Tomonori KIMURA
IPC分类号: G01N33/68
摘要: The present invention provides a method for assisting in the evaluation of the condition of kidneys, a system for evaluating the condition of kidneys, and a program for evaluating the condition of kidneys, using, as an index, the ratio of reabsorption of D-serine and/or D-asparagine in target kidneys and excretion of the D-serine and/or D-asparagine. The present invention also provides a method for monitoring the condition of kidneys and a method for monitoring the effect of treatment on kidney disease.
-
公开(公告)号:US20210373031A1
公开(公告)日:2021-12-02
申请号:US17286359
申请日:2019-10-17
发明人: Masashi MITA , Tatsuhiko IKEDA , Tomonori KIMURA
IPC分类号: G01N33/68
摘要: The present invention provides a method for determining glomerular filtration ability on the basis of the amount of D-serine in the blood. The present invention provides a blood analysis system which includes a storage unit, an analysis measurement unit, a data processing unit and a glomerular filtration ability output unit, wherein: the storage unit stores the correlation equation between the amount of D-serine in the blood and glomerular filtration ability; the analysis measurement unit separates and quantifies the amount of D-serine in the blood; the data processing unit calculates glomerular filtration ability by inputting the D-serine amount into the correlation equation stored in the storage unit; and a pathology information output unit outputs glomerular filtration ability information.
-
公开(公告)号:US20220003774A1
公开(公告)日:2022-01-06
申请号:US17374777
申请日:2021-07-13
申请人: Osaka University , Kagami Inc.
发明人: Yoshitaka ISAKA , Tomonori KIMURA , Keiko YASUDA , Kenji Hamase , Masashi MITA
摘要: The purpose of the present invention is to provide: a method for predicting the prognosis for kidney disease for a subject on the basis of the amount of D- and L-amino acids, from a blood sample; and an analysis system that determines prognosis predictions. This purpose is achieved by using at least one amino acid to predict the prognosis for kidney disease, said amino acid being selected from the group consisting of D-serine, D-asparagine, D-proline, D-alanine, D-leucine, D-lysine, D-allo-isoleucine, L-glutamic acid, L-alanine, L-tryptophan, and L-asparagine.
-
公开(公告)号:US20210373030A1
公开(公告)日:2021-12-02
申请号:US17286355
申请日:2019-10-17
发明人: Masashi MITA , Takashi WADA , Kengo FURUICHI , Norihiko SAKAI , Yasunori IWATA , Shinji KITAJIMA , Yusuke NAKADE
摘要: The present invention provides: a marker for determining critical stage kidney disease by using an indicator value based on the amount of D-alanine in the blood or the amount of D-alanine and L-alanine therein; a blood analysis method which uses said marker for patients undergoing surgery or intensive care; and a blood analysis system for determining critical stage kidney disease in patients undergoing surgery or intensive care.
-
公开(公告)号:US20210283082A1
公开(公告)日:2021-09-16
申请号:US16972906
申请日:2019-06-06
发明人: Takashi WADA , Kengo FURUICHI , Norihiko SAKAI , Yasunori IWATA , Akinori HARA , Yusuke NAKADE , Kenji HAMASE , Masashi MITA
IPC分类号: A61K31/198 , A61P13/12 , A61K9/00
摘要: The present invention pertains to a pharmaceutical composition for the prevention or treatment of kidney disease, an inflammation inhibitor for the kidneys, an inflammatory cell death inhibitor for the kidneys, or a food for the prevention or improvement of kidney disease, that include D-serine or a derivative thereof. In addition, the present invention pertains to the use of D-serine or a derivative thereof, for the production of a pharmaceutical composition for the prevention or treatment of kidney disease.
-
9.
公开(公告)号:US20240304331A1
公开(公告)日:2024-09-12
申请号:US18598428
申请日:2024-03-07
申请人: Kagami Inc. , National Institutes of Biomedical Innovation, Health and Nutrition , Osaka University
发明人: Atsunari Kawashima , Norio Nonomura , Ryoichi Imamura , Akinaru Yamamoto , Tomonori Kimura , Masashi Mita
CPC分类号: G16H50/20 , G01N33/6812 , G01N33/6893 , G01N33/70 , G16H20/10 , G01N2333/76 , G01N2333/8139 , G01N2800/347
摘要: Provided is a method for further improving therapeutic effect and cost efficiency by ascertaining cancer type and treatment responsiveness for individual patients. The invention provides a method which includes providing information regarding cancer type of a subject, comprising assessing the cancer type of the subject using a marker relating to the amount of a D-amino acid in blood of the subject, and providing information relating to the cancer type of the subject, based on the assessment results, as well as a system for providing information pertaining to cancer in a subject, which carries out the method.
-
10.
公开(公告)号:US20230220387A1
公开(公告)日:2023-07-13
申请号:US17789399
申请日:2020-12-25
申请人: Kagami Inc. , Public University Corporation Nara Medical University , National Institutes of Biomedical Innovation, Health and Nutrition
发明人: Masashi MITA , Rikako SUZUKI , Shushi NAGAMORI , Pattama WIRIYASERMKUL , Pornparn KONGPRACHA , Satomi MORIYAMA , Tomonori KIMURA
IPC分类号: C12N15/113 , A61K31/192 , A61K31/616 , A61K31/465 , A61K31/198 , A61K31/197
CPC分类号: C12N15/113 , A61K31/192 , A61K31/616 , A61K31/465 , A61K31/198 , A61K31/197 , C12N2310/14
摘要: The present invention provides a D-serine transport modifier which is characterized by controlling the transport of D-serine into and out of cells by a D-serine transporter protein, a pharmaceutical composition which comprises the same as an active component and treats or prevents diseases relating to an increase or decrease in the amount of D-serine, and a screening method of substances that control the transport of D-serine. The present invention also provides a screening method of a D-serine transporter protein.
-
-
-
-
-
-
-
-
-